|
28
|
115
|
7ejrA |
Crystal structure of v30m mutated transthyretin in complex with 8-chloro-9-oxo-9h-xanthene-3-carboxylic acid |
|
30
|
115
|
7ejqA |
Crystal structure of human transthyretin in complex with 8-chloro-9-oxo-9h-xanthene-3-carboxylic acid |
|
28
|
115
|
7dt5A |
Crystal structure of human transthyretin in complex with 4-chloro-9-oxo-9h-xanthene-2-carboxylic acid |
|
25
|
115
|
7dt6A |
Crystal structure of v30m mutated transthyretin in complex with purpurin |
|
28
|
115
|
7dt8A |
Crystal structure of v30m mutated transthyretin in complex with 4-chloro-9-oxo-9h-xanthene-2-carboxylic acid |
|
28
|
114
|
7dt3A |
Crystal structure of human transthyretin in complex with 4-chloro-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid |
|
27
|
115
|
6eoyA |
Transthyretin in complex with 4-(1,3-benzothiazol-2-yl)-2-methylaniline |
|
26
|
116
|
6suhA |
Crystal structure of human transthyretin in complex with 3-o-methyltolcapone, a tolcapone analogue |
|
28
|
116
|
6sugA |
Crystal structure of transthyretin in complex with 3-deoxytolcapone, a tolcapone analogue |
|
28
|
115
|
7acuA |
Crystal structure of human transthyretin in complex with benzbromarone |
|
23
|
115
|
6ti9A |
Human transthyretin (ttr) complexed with (e)-3-(((3,5-dibromo-2-hydroxybenzylidene)amino)oxy)propanoic acid. |
|
29
|
115
|
6u0qA |
Transthyretin in complex with (e)-5,5'-(ethene-1,2-diyl)bis(1,1-dihydroxy-3-oxo-1,3-dihydrobenzo[c][1,2]oxaborol-1-uide) |
|
27
|
116
|
6tjnA |
Human transthyretin (ttr) complexed with (e)-3-(((4-hydroxybenzylidene)amino)oxy)propanoic acid |
|
28
|
115
|
6kgbA |
Crystal structure of e61k mutated transthyretin |
|
26
|
116
|
6xtkA |
Y114c transthyretin structure in complex with tolcalpone |
|
27
|
116
|
6txvA |
A25t transthyretin structure in complex with tolcalpone |
|
25
|
116
|
6txwA |
V30g transthyretin structure in complex with tolcalpone |
|
0
|
113
|
6sdzA |
Transthyritin derived amyloid fibril from patient with hereditary v30m attr amyloidosis |
|
28
|
115
|
6e70A |
Structure of wild type human transthyretin in complex with diflunisal |
|
28
|
114
|
6e72A |
Structure of human transthyretin val30met mutant in complex with tafamidis |
|
27
|
115
|
6e6zA |
Structure of wild type human transthyretin in complex with tafamidis |
|
27
|
115
|
6e74A |
Structure of human transthyretin leu55pro mutant in complex with tafamidis |
|
24
|
114
|
6e78A |
Structure of human transthyretin asp38ala mutant in complex with diflunisal |
|
27
|
114
|
6e76A |
Structure of human transthyretin asp38ala/thr119met mutant |
|
27
|
115
|
6e73A |
Structure of human transthyretin val30met mutant in complex with diflunisal |
|
30
|
115
|
6e71A |
Structure of human transthyretin val30met/thr119met mutant |
|
29
|
115
|
6e77A |
Structure of human transthyretin asp38ala mutant in complex with tafamidis |
|
25
|
115
|
6e75A |
Structure of human transthyretin asp38ala mutant |
|
27
|
116
|
6r68A |
Crystal structure of transthyretin in complex with chf4795, a flurbiprofen analogue |
|
29
|
116
|
6r67A |
Crystal structure of transthyretin in complex with chf5075, a flurbiprofen analogue |
|
29
|
116
|
6r6iA |
Crystal structure of transthyretin mutant a25t in complex with chf5074, a flurbiprofen analogue |
|
27
|
115
|
6r66A |
Crystal structure of transthyretin in complex with chf5075, a flurbiprofen analogue |
|
26
|
115
|
6ep1A |
Transthyretin in complex with 5-(4-nitrophenylazo)-3-iodosalicylic acid |
|
29
|
115
|
6imyA |
Crystal structure of v30m mutated transthyretin in complex with 4'-caroboxybenzo-18-crown-6 |
|
28
|
115
|
6imxA |
Crystal structure of v30m mutated transthyretin in complex with 18-crown-6 |
|
29
|
116
|
6fftA |
Neutron structure of human transthyretin (ttr) s52p mutant in complex with tafamidis at room temperature to 2a resolution (quasi-laue) |
|
25
|
116
|
5nfwA |
Neutron structure of human transthyretin (ttr) s52p mutant at room temperature to 1.8a resolution (quasi-laue) |
|
26
|
116
|
5nfeA |
Neutron structure of human transthyretin (ttr) t119m mutant at room temperature to 1.85a resolution |
|
26
|
116
|
6fzlA |
Crystal structure of human transthyretin double mutant k35t/t119m |
|
28
|
116
|
6d0wA |
Structure of human transthyretin complex with analgesic inhibitor |
|
24
|
116
|
6fwdA |
Crystal structure of human transthyretin double mutant r34g/t119m at ph 5.5 |
|
27
|
116
|
6fxuA |
Crystal structure of human transthyretin mutant t119m at ph 5.5 |
|
25
|
116
|
5n7cA |
Human ttr altered conformation from soaking in cucl2. |
|
24
|
116
|
5n62A |
Human ttr crystals soaked in manganese chloride. |
|
30
|
116
|
5lllA |
Crystal structure of dacm wild type transthyretin |
|
25
|
116
|
5llvA |
Crystal structure of dacm f87m/l110m transthyretin mutant |
|
27
|
116
|
5l4fA |
Crystal structure of human transthyretin in complex with 2,6-dinitro-p-cresol (dnpc) |
|
24
|
116
|
5l4jA |
Crystal structure of human transthyretin in complex with 4,4'-dihydroxydiphenyl sulfone (bisphenol s, bps) |
|
25
|
116
|
5l4mA |
Crystal structure of human transthyretin in complex with 3,5,6-trichloro-2-pyridinyloxyacetic acid (triclopyr) |
|
31
|
116
|
5jidA |
Crystal structure of human transthyretin in complex with perfluorooctanoic acid (pfoa) |
